Validation of the Performance of the COBOX Solution for Measuring Heart Rate and Respiratory Rate
NCT ID: NCT05528042
Last Updated: 2022-09-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
323 participants
INTERVENTIONAL
2022-09-09
2022-09-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Quantiq.io software is a medical device which is :
contactless for the measurement non-invasive for the patient
In order to meet safety and quality standards, new health technologies require rigorous clinical validation with measurement performance at least equivalent to that of one CE marking measure device.
In this context, we assume that the COBOX device will take measurements of heart and respiratory rates equivalent to those taken by medical devices and current practices.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Contactless Measurement of Heart Rate, Heart Rate Variability and Breathing Rate Using Remote Photoplethysmography
NCT05889832
Pilot Study of the QI Device for Monitoring of Patients With Congestive Heart Failure
NCT02343523
Respiratory Disorders Non-invasive Monitoring of Work of Breathing in Outpatients
NCT04003415
Contactless Measurement of Heart Rate, Heart Rate Variability, Breathing Rate and Blood Pressure Using Remote Photoplethysmography
NCT06829615
Study on Cardiac Output Evaluation Based on Wearable Monitoring Data
NCT06938893
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Oral information to the patient about the test by the nursing staff.
2. Patient signs the consent.
3. Collection of the patient's age, gender and Fitzpatrick phototype.
4. Collection of the patient identification number.
5. The nursing staff installs the oximeter on the patient's finger.
6. The nursing staff starts COBOX and begins to count the patient's breath in parallel
7. After 15, a first measurement is made by COBOX. The pulse oximeter reference result is acquired in parallel.
8. After 20s (5s after the previous measurement) a second measurement is made by COBOX.
9. After 25s (5 after the previous measurement) a third measurement is made by COBOX.
10. After 30s, the nursing staff enters the number of patient's breaths counted since the start.
The performance of the tool will be estimated by the concordance between the measurements obtained from the application of the reference technical process via a CE marked device and with the measurements obtained by COBOX.
An intraclass correlation coefficient (ICC) with its 95% confidence interval (95% CI) will be calculated. Measurement errors will be calculated and expressed as a percentage (root mean square error, etc.).
The two study samples will be compared by Student's t test and Fischer's F, with a desired significance for P value = 0.05, for all the analyses.
A DIXON test will be performed to assess the presence of statistically outliers within the samples.
These data will enable the COBOX tool, a class IIA medical device, to be validated in terms of measurement performance compared to a CE-marked device used in a reference technical process for taking measurements and a reference method for manual counting.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
N/A, only one arm
All the patients that would like to participate and those where the inclusion criteria are past, are available to make the test. No drugs are administered.
Heart rate and respiratory rate measurement
Validation of the performance of the heart rate (HR) measurement using COBOX medical device compared to a measurement carried out by applying the reference processes for taking measurements via a CE marked device.
Evaluation of the performance of the respiratory rate (RR) measurement using COBOX medical device compared to a measurement carried out by a reference method of manual counting
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Heart rate and respiratory rate measurement
Validation of the performance of the heart rate (HR) measurement using COBOX medical device compared to a measurement carried out by applying the reference processes for taking measurements via a CE marked device.
Evaluation of the performance of the respiratory rate (RR) measurement using COBOX medical device compared to a measurement carried out by a reference method of manual counting
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient consulting in the emergency department of a participating center
* Patient having constant FC and FR taken by the reception organizing nurse (IOA) in the area dedicated to the reception of patients
* Patient who gave their consent to participate in the study
Exclusion Criteria
* Patient unable to express consent.
* Patient unable, for health reasons, to be face of COBOX.
* Patient unable to stay for 30 seconds facing the Cobox solution.
* Patient with skin stigma over more than 50% of the face (burn, graft)
* Patient with the face covered or not allowing access to the entire face (clothing)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Quantiq.io
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A00818-35
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.